Glioblastoma Overview
Learn About Glioblastoma
View Main Condition: Brain Tumor
Bozeman Health Deaconess Hospital
Justin Thomas is an Oncologist and a Hematologist Oncology provider in Bozeman, Montana. Dr. Thomas and is rated as an Advanced provider by MediFind in the treatment of Glioblastoma. His top areas of expertise are Appendix Cancer, Neuroendocrine Tumor, Familial Colorectal Cancer, and Lynch Syndrome. Dr. Thomas is currently accepting new patients.
Annie Castillo is a Hematologist Oncology specialist and an Oncologist in Bozeman, Montana. Dr. Castillo and is rated as an Experienced provider by MediFind in the treatment of Glioblastoma. Her top areas of expertise are Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Paget Disease of the Breast.
Bozeman Health Deaconess Hospital
William Conkright is a Hematologist Oncology specialist and a Hematologist in Bozeman, Montana. Dr. Conkright and is rated as an Experienced provider by MediFind in the treatment of Glioblastoma. His top areas of expertise are Triosephosphate Isomerase Deficiency, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Small Lymphocytic Lymphoma (SLL), and Thyroidectomy. Dr. Conkright is currently accepting new patients.
Summary: Despite comprehensive multimodal treatment of newly diagnosed glioblastoma, almost all patients suffer from tumour relapse. Currently, no standard of care exists to treat these tumour relapses. Treatment options include repeated surgery (if feasible), systemic therapy (bevacizumab, lomustine, temozolomide re-challenge), reirradiation and best supportive care. Currently, the superiority of combined...
Summary: Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/III response adaptive randomization platform trial designed to evaluate multiple therapies in newly diagnosed (ND) and recurrent GBM.

Keep Punching supports patients, healthcare providers, and researchers in their fight to prevent and eradicate brain cancer and minimize treatment-related side effects that may adversely impact function and comfort.